Nermeen N El-Agroudy1, Reem N El-Naga1, Rania Abd El-Razeq2, Ebtehal El-Demerdash3,4. 1. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. 2. Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. 3. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. ebtehal_dm@pharma.asu.edu.eg, ebtehal_dm@yahoo.com. 4. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Misr International University, Cairo, Egypt. ebtehal_dm@pharma.asu.edu.eg, ebtehal_dm@yahoo.com.
Abstract
BACKGROUND AND PURPOSE: Liver fibrosis is one of the leading causes of morbidity and mortality worldwide with very limited therapeutic options. Given the pivotal role of activated hepatic stellate cells in liver fibrosis, attention has been directed towards the signalling pathways underlying their activation and fibrogenic functions. Recently, the hedgehog (Hh) signalling pathway has been identified as a potentially important therapeutic target in liver fibrosis. The present study was designed to explore the antifibrotic effects of the potent Hh signalling inhibitor, forskolin, and the possible molecular mechanisms underlying these effects. EXPERIMENTAL APPROACH: Male Sprague-Dawley rats were treated with either CCl4 and/or forskolin for 6 consecutive weeks. Serum hepatotoxicity markers were determined, and histopathological evaluation was performed. Hepatic fibrosis was assessed by measuring α-SMA expression and collagen deposition by Masson's trichrome staining and hydroxyproline content. The effects of forskolin on oxidative stress markers (GSH, GPx, lipid peroxides), inflammatory markers (NF-κB, TNF-α, COX-2, IL-1β), TGF-β1 and Hh signalling markers (Ptch-1, Smo, Gli-2) were also assessed. KEY RESULTS: Hepatic fibrosis induced by CCl4 was significantly reduced by forskolin, as indicated by decreased α-SMA expression and collagen deposition. Forskolin co-treatment significantly attenuated oxidative stress and inflammation, reduced TGF-β1 levels and down-regulated mRNA expression of Ptch-1, Smo and Gli-2 through cAMP-dependent PKA activation. CONCLUSION AND IMPLICATIONS: In our model, forskolin exerted promising antifibrotic effects which could be partly attributed to its antioxidant and anti-inflammatory effects, as well as to its inhibition of Hh signalling, mediated by cAMP-dependent activation of PKA.
BACKGROUND AND PURPOSE:Liver fibrosis is one of the leading causes of morbidity and mortality worldwide with very limited therapeutic options. Given the pivotal role of activated hepatic stellate cells in liver fibrosis, attention has been directed towards the signalling pathways underlying their activation and fibrogenic functions. Recently, the hedgehog (Hh) signalling pathway has been identified as a potentially important therapeutic target in liver fibrosis. The present study was designed to explore the antifibrotic effects of the potent Hh signalling inhibitor, forskolin, and the possible molecular mechanisms underlying these effects. EXPERIMENTAL APPROACH: Male Sprague-Dawley rats were treated with either CCl4 and/or forskolin for 6 consecutive weeks. Serum hepatotoxicity markers were determined, and histopathological evaluation was performed. Hepatic fibrosis was assessed by measuring α-SMA expression and collagen deposition by Masson's trichrome staining and hydroxyproline content. The effects of forskolin on oxidative stress markers (GSH, GPx, lipid peroxides), inflammatory markers (NF-κB, TNF-α, COX-2, IL-1β), TGF-β1 and Hh signalling markers (Ptch-1, Smo, Gli-2) were also assessed. KEY RESULTS:Hepatic fibrosis induced by CCl4 was significantly reduced by forskolin, as indicated by decreased α-SMA expression and collagen deposition. Forskolin co-treatment significantly attenuated oxidative stress and inflammation, reduced TGF-β1 levels and down-regulated mRNA expression of Ptch-1, Smo and Gli-2 through cAMP-dependent PKA activation. CONCLUSION AND IMPLICATIONS: In our model, forskolin exerted promising antifibrotic effects which could be partly attributed to its antioxidant and anti-inflammatory effects, as well as to its inhibition of Hh signalling, mediated by cAMP-dependent activation of PKA.
Authors: Haofeng Ji; Xiu-da Shen; Yu Zhang; Feng Gao; Cynthia Y Huang; William W Chang; Coney Lee; Bibo Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski Journal: Liver Transpl Date: 2012-06 Impact factor: 5.799
Authors: A Mallat; A M Préaux; C Serradeil-Le Gal; D Raufaste; C Gallois; D A Brenner; C Bradham; J Maclouf; V Iourgenko; L Fouassier; D Dhumeaux; P Mavier; S Lotersztajn Journal: J Clin Invest Date: 1996-12-15 Impact factor: 14.808
Authors: Alessia Omenetti; Wing-Kin Syn; Youngmi Jung; Heather Francis; Alessandro Porrello; Rafal P Witek; Steve S Choi; Liu Yang; Marlyn J Mayo; M Eric Gershwin; Gianfranco Alpini; Anna Mae Diehl Journal: Hepatology Date: 2009-08 Impact factor: 17.425
Authors: Y Y Lee; D Moujalled; M Doerflinger; L Gangoda; R Weston; A Rahimi; I de Alboran; M Herold; P Bouillet; Q Xu; X Gao; X-J Du; H Puthalakath Journal: Cell Death Differ Date: 2013-04-12 Impact factor: 15.828
Authors: Jörg H W Distler; Andrea-Hermina Györfi; Meera Ramanujam; Michael L Whitfield; Melanie Königshoff; Robert Lafyatis Journal: Nat Rev Rheumatol Date: 2019-11-11 Impact factor: 20.543